Expert Review of Anticancer Therapy, Volume 23, Issue 1 (2023)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Anticancer Therapy, Volume 23, Issue 1 (2023)

See all volumes and issues
Vol 24, 2024 Volume 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Editorial

Editorial
Oligometastases in head and neck squamous cell carcinoma patients
Remco de Bree, Jose A. Hardillo & Mischa de Ridder
Pages: 1-3
Published online: 18 Nov 2022
First Page PreviewforOligometastases in head and neck squamous cell carcinoma patients | Full Text | References | PDF (136.7 KB) | EPUB
  • 1046 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Perspective

Article
The role of autophagy in acute myeloid leukemia development
Martyna Bednarczyk, Karolina Kociszewska, Olga Grosicka & Sebastian Grosicki
Pages: 5-18
Published online: 02 Jan 2023
AbstractforThe role of autophagy in acute myeloid leukemia development | Full Text | References | PDF (1.1 MB) | EPUB
  • 314 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review
Five years of lenvatinib in hepatocellular carcinoma: are there any predictive and/or prognostic factors?
Mara Persano, Andrea Casadei-Gardini, Valentina Burgio, Mario Scartozzi, Stefano Cascinu & Margherita Rimini
Pages: 19-27
Published online: 14 Dec 2022
AbstractforFive years of lenvatinib in hepatocellular carcinoma: are there any predictive and/or prognostic factors? | Full Text | References | PDF (264.6 KB) | EPUB
  • 318 Views
  • 1 CrossRef citations
  • 0Altmetric
Review
Current treatment approaches for brain metastases in ALK/ROS1/NTRK-positive non-small-cell lung cancer
Sabrina Rossi, Arianna Marinello, Arianna Pagliaro, Davide Franceschini, Pierina Navarria, Giovanna Finocchiaro, Luca Toschi, Marta Scorsetti & Armando Santoro
Pages: 29-41
Published online: 29 Dec 2022
AbstractforCurrent treatment approaches for brain metastases in ALK/ROS1/NTRK-positive non-small-cell lung cancer | Full Text | References | PDF (350.2 KB) | EPUB
  • 312 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
The current clinical approach to difficult-to-treat basal cell carcinomas
Eugenia Veronica Di Brizzi, Giuseppe Argenziano, Gabriella Brancaccio, Camila Scharf, Andrea Ronchi & Elvira Moscarella
Pages: 43-56
Published online: 02 Jan 2023
AbstractforThe current clinical approach to difficult-to-treat basal cell carcinomas | Full Text | References | PDF (7.7 MB) | EPUB
  • 180 Views
  • 2 CrossRef citations
  • 0Altmetric
Review
Current status and novel insights into the role of metastasectomy in the era of immunotherapy
Efstathia Liatsou, Diamantis I. Tsilimigras, Panagiotis Malandrakis, Maria Gavriatopoulou & Ioannis Ntanasis-Stathopoulos
Pages: 57-66
Published online: 22 Dec 2022
AbstractforCurrent status and novel insights into the role of metastasectomy in the era of immunotherapy | Full Text | References | PDF (281.3 KB) | EPUB
  • 157 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
Neoadjuvant endocrine therapy in postmenopausal women with HR+/HER2- breast cancer
Carlos Martínez-Pérez, Arran K Turnbull, Charlene Kay & J Michael Dixon
Pages: 67-86
Published online: 19 Jan 2023
AbstractforNeoadjuvant endocrine therapy in postmenopausal women with HR+/HER2- breast cancer | Full Text | References | PDF (676.3 KB) | EPUB
  • 2406 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

Systematic Review

Systematic Review
The clinical relationship between histamine-1 receptor antagonists and risk of cancer: a systematic review and meta-analysis
Elham Bakhtiari, Nasrin Moazzen, Amir Amirabadi & Hamid Ahanchian
Pages: 87-94
Published online: 15 Dec 2022
AbstractforThe clinical relationship between histamine-1 receptor antagonists and risk of cancer: a systematic review and meta-analysis | Full Text | References | PDF (2.4 MB) | EPUB
  • 107 Views
  • 1 CrossRef citations
  • 0Altmetric

Original Research

Article
Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for EGFR exon 20 insertion–positive non–small cell lung cancer
James Chih-Hsin Yang, Caicun Zhou, Pasi A. Jänne, Suresh S. Ramalingam, Tae Min Kim, Gregory J Riely, Alexander I Spira, Zofia Piotrowska, Tarek Mekhail, Maria Rosario Garcia Campelo, Enriqueta Felip, Lyudmila Bazhenova, Shu Jin, Manmit Kaur, Paul M. Diderichsen, Neeraj Gupta, Veronica Bunn, Jianchang Lin, Eric N. Churchill, Minal Mehta & Danny Nguyen
Pages: 95-106
Published online: 28 Dec 2022
AbstractforCharacterization and management of adverse events observed with mobocertinib (TAK-788) treatment for EGFR exon 20 insertion–positive non–small cell lung cancer | Full Text | References | PDF (704.2 KB) | EPUB | Supplemental
  • 3718 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Meta-analysis

Effect of primary tumor resection on survival in patients with asymptomatic unresectable metastatic colorectal cancer: a systematic review and meta-analysis
Chengren Zhang, Cong Cao, Lili Liu, Yaochun Lv, Jingjing Li, Jiyong Lu, Shuai Wang, Binbin Du & Xiongfei Yang
Pages: 107-115
Published online: 25 Nov 2022
AbstractforEffect of primary tumor resection on survival in patients with asymptomatic unresectable metastatic colorectal cancer: a systematic review and meta-analysis | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 193 Views
  • 1 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Immune-related adverse events associated with mogamulizumab: a comprehensive review of the literature
Genevieve S. Silva et al.
Review Article | Published online: 23 Jul 2024
Bevacizumab-containing treatment for relapsed or refractory Wilms tumor
Sarah Al-Jilaihawi et al.
Review Article | Published online: 23 Jul 2024
UNDERSTANDING the LINK BETWEEN ASPARTAME and CANCER
Morando Soffritti
Report | Published online: 23 Jul 2024
PROTACing the androgen receptor and other emerging therapeutics in prostate cancer
Peter D. Zang et al.
Review Article | Published online: 22 Jul 2024
View all latest articles